Chemical And Biomolecular Engineering
News
Faculty Opening at the Associate Professor or Professor Rank
Prof. Konstantopoulos elected a fellow of the Biomedical Engineering Society (BMES)
Profs. Schulman and Cui receive the National Science Foundation Career Award
Profs. Bevan and Frechette organize the 86th ACS Colloids and Surfaces meeting: This conference at JHU featured talks from over 500 national and international participants.
Chemical sequence replication: In a recent publication in PNAS, Prof. Schulman and co-authors demonstrate that chemical sequences made from designed nanoscale building blocks can self-replicate that is approaching the accuracy of the PCR method used to amplify DNA, suggesting a way to replicate and evolve functional nanostructures.
Donohue appointed to Leadership Role at the Council for Chemical Research: Prof. Donohue was appointed Vice Chair of Board of Directors and Annual Meeting Program Chair, Council for Chemical Research.
Self-assembly research from Gracias lab featured on Science Nation.
Sravanti Kusuma (Gerecht lab) and Courtney Gonzalez (Ostermeier lab) receive NIH Pre-doctoral fellowships: These fellowships are awarded to promising applicants with the potential to become productive, independent, highly trained scientists.
Schulman receives a major grant from the NSF: Prof. Schulman co-leads a collaboration that is a awarded a $1M grant from the NSF to use synthetic biomolecules to engineer complex pattern formation similar to what occurs during biological development.
Skin regeneration: In a recent publication in PNAS, a specially designed polysaccharide hydrogel developed in the Gerecht lab was shown to induce rapid blood vessel penetration into severe burned tissues, enabling complete skin regeneration with new hair growth.
Discover Magazine's Top 100 Stories of 2011 included the Ostermeier lab's development of a protein switch that selectively kills cancer cells. The protein switch concept offers a platform for the development of inherently selective protein therapeutics for cancer and other diseases.
Bevan receives a major grant from the NSF Cyber Enabled Discovery and Innovation program: In an effort led by Prof. Bevan, this $1.6M grant funds four PIs at four institutions to investigate new ideas related to the First-Principles Based Control of Multi-Scale Meta-Material Assembly Processes.
Self-assembling curved microfluidics: Drawing inspiration from vascularized biological systems such as leaves and tissues, paper from the Gracias lab in Nature Communications discusses the self-assembly of curved microfluidic devices.
Smart protein therapeutics: As discussed in a paper in PNAS, the Ostermeier lab has developed a novel approach to protein therapeutics in which protein switches turn on their cell-killing activity preferentially in cancer cells.
JHU ChemBE Fast Facts
- 18 Full-time faculty
- 324 Undergrads, 63 Grads
- JHU is ranked 13th overall in the nation
- Two major graduate programs in nanobiotechnology
- Faculty published 90 papers in 2011
- Our total research volume for FY2011 was 753K
- Hopkins ChemBE ranked 9th (Faculty Scholarly Productivity Index, 2006)
- JHU (including the Applied Physics Laboratory and School of Medicine) is first in overall research funding
|
Graduate Training Programs in NanoBioTechnology
The Institute for NanoBioTechnology at Johns Hopkins University will
revolutionize health care by bringing together internationally renowned
expertise in medicine, engineering, the sciences, and public health to
create new knowledge and groundbreaking technologies.
>> find
out more...
- NanoBio IGERT -The NSF sponsored Integrative Graduate Education and Research Traineeship (IGERT) is a pre-doctoral / graduate training program that teaches students how to design and develop nanoprobes such as functionalized nanoparticles and lab-on-a-chip technologies.
- NBMed
- The Johns Hopkins University Interdisciplinary Graduate Training
Program in Nanotechnology for Biology and Medicine-or NBMed program-is
an exciting graduate / pre-doctoral training program housed in the
Institute for NanoBioTechnology.
The program focuses on a new frontier for scientific exploration: the interface between nanotechnology, biology, and medicine for creating new diagnostics and therapeutics to detect, treat, cure, and prevent human diseases.
Funding for the program comes from the Howard Hughes Medical Institute.



